Search
for

    Sort by

    Research 30 of 65

    1. Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data Pharmaceuticals · 2026
    2. Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series Life · 2026
    3. Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report Cureus · 2026
    4. current possible treatment approaches of Polycystic Ovary Syndrome (PCOS) Journal of Education, Health and Sport · 2024
    5. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing International Journal of Molecular Sciences · 2022 · 68 citations
    6. A 6-Month Prospective, Open-Label, Randomized Study Showing Increased Hair Growth Rate in Women Using Multi-Targeting Hair Growth Nutraceuticals Dermatology and Therapy · 2026
    7. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    8. Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs Journal of Clinical Medicine · 2023 · 29 citations
    9. Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome Journal of Neonatal Surgery · 2025
    10. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    11. GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions 2025
    12. The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome Journal of Clinical Medicine · 2023
    13. Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland Nutrients · 2023 · 1 citations
    14. WNT Signaling in Disease Cells · 2019 · 144 citations
    15. Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review Clinical Phytoscience · 2021 · 17 citations
    16. From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries International Journal on Science and Technology · 2026
    17. Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment Research Journal for Social Affairs · 2024
    18. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    19. <i>Acorus calamus</i>: a bio-reserve of medicinal values 2018 · 45 citations
    20. Debatable Topics in PCOS Patients InTech eBooks · 2018 · 2 citations
    21. A review on PCOS: Its causes, symptoms, pathogenesis and management World Journal of Advanced Pharmaceutical and Medical Research · 2024 · 1 citations
    22. Can gut flora changes be new biomarkers for depression? Frontiers in Laboratory Medicine · 2017 · 1 citations
    23. The Impact of Bariatric Surgery on the Development and Progression of Dermatologic Diseases: A Narrative Review Dermatology and Therapy · 2025
    24. EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS Biological and Clinical Sciences Research Journal · 2024
    25. Hormones Elsevier eBooks · 2018 · 4 citations
    26. Understanding Polycystic Ovary Syndrome Directory of Open access Books (OAPEN Foundation) · 2025
    27. Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha Open Repository of the University of Porto (University of Porto) · 2024
    28. Farmácia Avenida Brasil, Porto Open Repository of the University of Porto (University of Porto) · 2023
    29. Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes Journal of Clinical Medicine · 2026
    30. New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching Preprints.org · 2026